📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Expanded population of CD1d-restricted Va24+ cells in a patient with active rheumatoid arthritis. (2014)

First Author: Gutowska-Owsiak D

Attributed to: RegenVOX: phase I/II clinical trial of stem cell based tissue engineered laryngeal implants funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.clim.2013.11.006

PubMed Identifier: 24412906

Publication URI: http://europepmc.org/abstract/MED/24412906

Type: Journal Article/Review

Volume: 150

Parent Publication: Clinical immunology (Orlando, Fla.)

Issue: 2

ISSN: 1521-6616